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Since Gowans first discovered the importance of lymphocytes in the immune
response [1], a gradual understanding of their biology has evolved. Initially, B
lymphocytes, the effector cells of humoral immunity, were studied in great detail.
Largely because ofthe ability to obtain huge quantities ofhomogeneous antibodies-
the B cell's primary product-through the study of multiple myeloma, tremendous
gains were made in understanding the B lymphocyte's active role in immunity.
The T cell, however, remained more intractable; without the ease of obtaining an
entity analogous to an antibody molecule, other approaches were necessary. The
biology of cytotoxic T lymphocytes was studied by examining their ability to lyse
foreign cells. Yet the cells which are most important in understandingthe physiologic
control of the immune response, the regulatory T lymphocytes, have been the most
difficult to comprehend.
In June of 1979, a symposium sponsored by Columbia University was held on this
topic, bringing together most of the world's experts in this area. The proceedings of
this meeting, the fourth of the P. and S. Biomedical Sciences Symposia, edited by
Benvenuto Pernis and Henry J. Vogel, represents an outstanding summary of work
in this field.
The volume is divided into seven sections, initially examining T cell receptors and
T subpopulations before going into detailed discussions of both murine and human
helper and suppressor T lymphocytes. Finally, regulatoryT cell circuits are described
in an attempt to synthesize present knowledge in the area into a coherent model.
The book first examines one of the more basic yet elusive characteristics of T
lymphocytes, the T cell receptor, determinant of T cell specificity. Although it is well
documented that T lymphocytes do not bear conventional immunoglobulin mole-
cules or intact L chains, it has been elegantly shown that they do express idiotypic
determinants shared by B cells specific for the same antigen. Oneapproach described
has been to try to propagate clones of T cells which secrete soluble molecules
mediating their antigen-specific regulatory functions, analogous to studying B cells
through their immunoglobulins.
Another approach to studying T lymphocytes has been to take advantage of the
cell surface differentiation antigens which are specific for various sub-classes of T
lymphocytes. With the use of monoclonal antibodies against these markers, a more
detailed analysis ofT function can be performed. Employing a fluorescence-activated
cell sorter, for example, one is able to determine the fraction of cells expressing a
given differentiation antigen in a population, and to correlate such structural
information with the cell's function. Furthermore, these antibodies can be used
selectively to enrich or deplete a given subpopulation of cells, or to interfere with
their actions, providing more information on the function associated with such a
subset.
While work on regulatory T cells was initially confined to animal systems, recent
work has correlated data obtained from various species to that from humans; this is
particularly evident in the area of disorders in regulation. For example, a wide range
of immune deficiency diseases have now been ascribed to the presence ofabnormally
large numbers or overly activated suppressor T cells; at the other extreme, depletion
of suppressor cell activity has been implicated in autoimmune disorders. It has also
been claimed that suppressor cells play a role in the immunologic enhancement of
tumor growth. Each of these imbalances in regulation, it may be added, also suggests
potential avenues for immunoprophylaxis or immunotherapy.
313 BOOK REVIEWS314 BOOK REVIEWS
The final section ofthe volume is devoted to discussions ofregulatory T circuits in
an effort to consolidate the experimental data into an understanding ofthe physio-
logic control of the immune response. Employing the concept of "id^" and "id" T
regulatory cells (for those T lymphocytes bearing idiotypes either identical or
complementary to that of the B cell being controlled), Herzenberg et al. have
proposed the concept of the core regulatory circuit. In it, two sets of helper T cells
and two sets of suppressor T cells modulate each other in a cyclic fashion, the
outcome of which determines whether a given B lymphocyte is helped or suppressed.
Presumably all soluble factor- and macrophage-mediated interactions affecting B cell
response do so by altering the equilibrium of this four-cell circuit. As with Jerne's
original formulation of a network hypothesis to explain immune regulation [2], such
a theory represents a good framework from which to ask future questions and to
build a more comprehensive model of lymphocyte interactions.
The constantly changing nature of cellular immunology makes it difficult for any
one book to cover the field adequately. However, the papers in this volume, which
are uniformly well written, present new data as well as summarize years of previous
work by most of the leading laboratories in the area. As such, this volume represents
an excellent, fairly up-to-date review of regulatory T cells, as well as a useful guide to
new work in this rapidly emerging field.
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The Second Annual Bristol-Myers Symposium on Cancer Research was truly a
whirlwind affair. Hosted by the Yale University Department of Pharmacology and
the Developmental Therapeutics Program of the Comprehensive Cancer Center,
twenty-nine internationally known scientists presented papers to nearly five hundred
participants over two days (November 8-9, 1979) at the Sheraton-Park Plaza Hotel
in New Haven, CT. The effects of such a program on this reviewer were exhilarating
yet unsatisfying. Limited to twenty minutes for presentation and a fifteen-minute
panel discussion at the end of a session, each lecturer worked crisply to lay down the
fundamentals of the research and hoped to break some new ground before time
expired. Any temptation to pause and reflect must be stronglysuppressed duringthis
type of rapid-fire delivery, and therein lies the rub. Needless to say, this handsome
volume of the proceedings is a welcome, detailed account of this impressive
symposium and stands on its own as an important compendium of some of the
current frontiers of cancer research.
The book contains twenty-eight papers (one speaker failed to contribute) which are
grouped into seven parts, following the outline of the symposium. Part I, entitled
"Alkylating Agents," begins with discussions of the mechanisms and targets of
clinically relevant drugs such as the nitrogen mustards and platinum compounds by
Drs. K.W. Kohn, J.J. Roberts, and K.R. Harrap. Particularly noteworthy in terms of